Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1996 3
1997 5
1998 4
1999 5
2000 5
2001 3
2002 4
2003 8
2004 8
2005 5
2006 7
2007 8
2008 11
2009 13
2010 8
2011 13
2012 17
2013 13
2014 15
2015 14
2016 5
2017 5
2018 10
2019 10
2020 9
2021 12
2022 10
2023 11
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

217 results

Results by year

Filters applied: . Clear all
Page 1
Telmisartan, ramipril, or both in patients at high risk for vascular events.
ONTARGET Investigators; Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C. ONTARGET Investigators, et al. N Engl J Med. 2008 Apr 10;358(15):1547-59. doi: 10.1056/NEJMoa0801317. Epub 2008 Mar 31. N Engl J Med. 2008. PMID: 18378520 Free article. Clinical Trial.
Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies.
Pocock SJ, Ariti CA, McMurray JJ, Maggioni A, Køber L, Squire IB, Swedberg K, Dobson J, Poppe KK, Whalley GA, Doughty RN; Meta-Analysis Global Group in Chronic Heart Failure. Pocock SJ, et al. Among authors: doughty rn. Eur Heart J. 2013 May;34(19):1404-13. doi: 10.1093/eurheartj/ehs337. Epub 2012 Oct 24. Eur Heart J. 2013. PMID: 23095984
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.
Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators; Yusuf S, Teo K, Anderson C, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P. Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators, et al. Lancet. 2008 Sep 27;372(9644):1174-83. doi: 10.1016/S0140-6736(08)61242-8. Epub 2008 Aug 29. Lancet. 2008. PMID: 18757085 Clinical Trial.
Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality.
Schunk SJ, Kleber ME, März W, Pang S, Zewinger S, Triem S, Ege P, Reichert MC, Krawczyk M, Weber SN, Jaumann I, Schmit D, Sarakpi T, Wagenpfeil S, Kramann R, Boerwinkle E, Ballantyne CM, Grove ML, Tragante V, Pilbrow AP, Richards AM, Cameron VA, Doughty RN, Dubé MP, Tardif JC, Feroz-Zada Y, Sun M, Liu C, Ko YA, Quyyumi AA, Hartiala JA, Tang WHW, Hazen SL, Allayee H, McDonough CW, Gong Y, Cooper-DeHoff RM, Johnson JA, Scholz M, Teren A, Burkhardt R, Martinsson A, Smith JG, Wallentin L, James SK, Eriksson N, White H, Held C, Waterworth D, Trompet S, Jukema JW, Ford I, Stott DJ, Sattar N, Cresci S, Spertus JA, Campbell H, Tierling S, Walter J, Ampofo E, Niemeyer BA, Lipp P, Schunkert H, Böhm M, Koenig W, Fliser D, Laufs U, Speer T; eQTLGen consortium; BIOS consortium. Schunk SJ, et al. Among authors: doughty rn. Eur Heart J. 2021 May 7;42(18):1742-1756. doi: 10.1093/eurheartj/ehab107. Eur Heart J. 2021. PMID: 33748830 Free PMC article.
The diabetes-atrial fibrillation paradox.
Tan ESJ, Tay WT, Teng TK, Richards AM, Doughty RN, Lam CSP. Tan ESJ, et al. Among authors: doughty rn. Heart. 2019 Jun;105(11):893. doi: 10.1136/heartjnl-2019-315018. Heart. 2019. PMID: 31092681 No abstract available.
Endotrophin, a Collagen VI Formation-Derived Peptide, in Heart Failure.
Chirinos JA, Zhao L, Reese-Petersen AL, Cohen JB, Genovese F, Richards AM, Doughty RN, Díez J, González A, Querejeta R, Zamani P, Nuñez J, Wang Z, Ebert C, Kammerhoff K, Maranville J, Basso M, Qian C, Rasmussen DGK, Schafer PH, SeifFert D, Karsdal MA, Gordon DA, Ramirez-Valle F, Cappola TP. Chirinos JA, et al. Among authors: doughty rn. NEJM Evid. 2022 Oct;1(10):10.1056/evidoa2200091. doi: 10.1056/evidoa2200091. Epub 2022 Sep 13. NEJM Evid. 2022. PMID: 37645406 Free PMC article.
Proteomic Analysis of Effects of Spironolactone in Heart Failure With Preserved Ejection Fraction.
Javaheri A, Diab A, Zhao L, Qian C, Cohen JB, Zamani P, Kumar A, Wang Z, Ebert C, Maranville J, Kvikstad E, Basso M, van Empel V, Richards AM, Doughty RN, Rietzschel E, Kammerhoff K, Gogain J, Schafer P, Seiffert DA, Gordon DA, Ramirez-Valle F, Mann DL, Cappola TP, Chirinos JA. Javaheri A, et al. Among authors: doughty rn. Circ Heart Fail. 2022 Sep;15(9):e009693. doi: 10.1161/CIRCHEARTFAILURE.121.009693. Epub 2022 Aug 9. Circ Heart Fail. 2022. PMID: 36126144 Free PMC article. Clinical Trial.
Temporal trends in the burden of heart failure.
Chan DZL, Kerr AJ, Doughty RN. Chan DZL, et al. Among authors: doughty rn. Intern Med J. 2021 Aug;51(8):1212-1218. doi: 10.1111/imj.15253. Intern Med J. 2021. PMID: 33650267 Review.
Iron deficiency in patients with heart failure.
Fitzsimons S, Doughty RN. Fitzsimons S, et al. Among authors: doughty rn. Eur Heart J Cardiovasc Pharmacother. 2015 Jan;1(1):58-64. doi: 10.1093/ehjcvp/pvu016. Eur Heart J Cardiovasc Pharmacother. 2015. PMID: 27533968 Review.
Role of transthoracic echocardiogram in acute heart failure.
Fitzsimons S, Doughty RN. Fitzsimons S, et al. Among authors: doughty rn. Rev Cardiovasc Med. 2021 Sep 24;22(3):741-754. doi: 10.31083/j.rcm2203081. Rev Cardiovasc Med. 2021. PMID: 34565073 Free article. Review.
217 results